Takeda
Pharma firms give researchers access
July 22, 2014Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library
UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …
Takeda and Lilly hit with $9 billion Actos damages bill
April 8, 2014Medical Communications, Sales and Marketing Actos, Takeda, law case, lilly
A US jury has ordered Japanese firm Takeda Pharmaceutical to pay $6 billion (£3.6 billion) in punitive damages, over claims …
Takeda hires head of emerging markets
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, giles platford
Giles Platford has been appointed head of commercial operations, emerging markets for Swiss-based pharma firm Takeda. Reporting to its chief …
Nuevolution hires Takeda head as chief business officer
December 10, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, neuvolution
Small molecule lead discovery firm Nuevolution has poached Ton Berkien from Takeda to join the firm as a chief business …
GSK veteran named chief executive for Takeda
December 2, 2013Sales and Marketing GSK, Takeda, christophe weber
Asia’s biggest drugmaker Takeda has named GlaxoSmithKline’s Christophe Weber as the leading candidate for the role of its next chief …
Brintellix ‘yes’ from FDA
October 4, 2013Sales and Marketing FDA, Lundbeck, Takeda, brintellix
Takeda Pharmaceutical Company and Lundbeck are celebrating after the FDA approved their depression treatment Brintellix – despite there being no …
Astellas hires senior VP from rival Takeda
August 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology
Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …
Pfizer wins $2.15 billion patent case
June 13, 2013Sales and Marketing Pfizer, Takeda, Teva, protonix
Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …
Promise for Lundbeck and Takeda’s depression drug
May 20, 2013Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly
Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
Takeda to buy Inviragen
May 10, 2013Research and Development, Sales and Marketing Inviragen, Takeda
Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …
Takeda rapped over quality control failure in Japan
April 19, 2013Manufacturing and Production GMP, OPMA, Takeda
Takeda Pharmaceutical has been penalised by its local trade organisation over the quality failings that led to the recall of …
Probe launched as deaths prompt Omontys recall
February 26, 2013Manufacturing and Production Affymax, Takeda, omontys, recall
Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …
CMO plant shut down after Takeda product recall
February 19, 2013Manufacturing and Production CMP, OPG, Takeda
Japan’s regulatory authorities flexed their enforcement muscles last week when it ordered a temporary shutdown of the contract manufacturer for …
Takeda gets US diabetes approval
January 28, 2013Sales and Marketing FDA, Nesina, Takeda, diabetes
Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …
Takeda to buy Envoy Therapeutics
November 7, 2012Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda
Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
